A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers
Clinical trial NCT07176975 · SUSPENDED
Trial details
- NCT number
- NCT07176975
- Sponsor
- Boehringer Ingelheim
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-08-03
- Primary completion
- 2028-12-19
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.